Editas Medicine, Inc. (NASDAQ:EDIT) Sees Unusual Trading Volume in Its SharesModern ReadersCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotella a… Continue reading
Editas Medicine, Inc. (NASDAQ:EDIT) Sees Unusual Trading Volume in Its SharesModern ReadersCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotella a… Continue reading
Editas Medicine, Inc. (NASDAQ:EDIT) Sees Heavy Trading Volume with 1845K Shares Changing HandsHighlight PressCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (… Continue reading
AsiaOneStem cell recipient, donor meet 13 years after transplantAsiaOneUntil last week, leukemia survivor Fengfeng (not his real name) knew almost nothing about the person who saved his life 13 years ago. Holding a bouquet of flowers, Fengfeng spotted … Continue reading
NewsweekNew Magic Mushrooms Discovery Could Reveal How to Make Your Own DrugsNewsweekThe paper could pave the way for people without advanced knowledge to produce psilocybin on their own, using commercially available synthetic biology kits, Sherman say… Continue reading
NewsweekNew Magic Mushrooms Discovery Could Reveal How to Make Your Own DrugsNewsweekThe paper could pave the way for people without advanced knowledge to produce psilocybin on their own, using commercially available synthetic biology kits, Sherman say… Continue reading
FuturismScientists Have Developed a New Method to 3D-Print Living TissueFuturismTo avoid this, the Oxford team, led by 3D-bioprinting scientist Alexander Graham from Oxford Synthetic Biology (OxSyBio), contained their cells within nanolitre droplets th… Continue reading
Duke Today |
Gold Nanostars and Immunotherapy Vaccinate Mice Against Cancer
Duke Today The new approach relies on a “photothermal immunotherapy” technology developed by an interdisciplinary group of Duke researchers that uses lasers and gold nanostars to heat up and destroy tumors in combination with an immunotherapeutic drug. |